I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hodi, F. Stephen
519
results:
Format
Online (519)
Mediatypes
E-Books (1)
Articles (Online) (196)
Bookchapter (Online) (2)
OpenAccess-fulltext (320)
Languages
german (1)
english (444)
more...
french (2)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Thomas F. Gajewski and F. Stephen Hodi (eds): Targeted ther..:
Dutcher, Janice P.
Medical Oncology. 30 (2013) 1 - p. , 2013
Link:
https://doi.org/10.1007/..
?
2
Ziv-aflibercept plus pembrolizumab in patients with advance..:
Baginska, Joanna
;
Nau, Allison
;
Gomez Diaz, Ilana
...
Cancer Immunology, Immunotherapy. 73 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1007/..
?
3
Phase II trial of vaccination with autologous, irradiated m..:
Sussman, Tamara A.
;
Severgnini, Mariano
;
Giobbie-Hurder, Anita
...
Frontiers in Oncology. 14 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
4
Correction: Combination of Itacitinib or Parsaclisib with P..:
Munster, Pamela
;
Iannotti, Nicholas
;
Cho, Daniel C.
...
Cancer Research Communications. 4 (2024) 3 - p. 785-785 , 2024
Link:
https://doi.org/10.1158/..
?
5
Transmural Flow Upregulates PD‐L1 Expression in Microvascul..:
Wan, Zhengpeng
;
Zhang, Shun
;
Zhong, Amy X.
...
Advanced Science. 11 (2024) 26 - p. , 2024
Link:
https://doi.org/10.1002/..
?
6
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523)..:
Buchbinder, Elizabeth I.
;
Cohen, Justine V.
;
Tarantino, Giuseppe
...
Cancer Research Communications. 4 (2024) 5 - p. 1321-1327 , 2024
Link:
https://doi.org/10.1158/..
?
7
Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatiti..:
Li, Michael
;
Wong, Danny
;
Sack, Jordan S.
...
Clinical Gastroenterology and Hepatology. 22 (2024) 7 - p. 1444-1452.e4 , 2024
Link:
https://doi.org/10.1016/..
?
8
Safety, pharmacokinetics, pharmacodynamics, and antitumor a..:
Baranda, Joaquina C.
;
Robbrecht, Debbie
;
Sullivan, Ryan
...
Clinical and Translational Science. 17 (2024) 6 - p. , 2024
Link:
https://doi.org/10.1111/..
?
9
A phase Ib trial of combined PKC and MEK inhibition with so..:
Bauer, Sebastian
;
Larkin, James
;
Hodi, F. Stephen
...
Frontiers in Oncology. 12 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
10
Liquid biopsy epigenomic profiling for cancer subtyping:
Baca, Sylvan C.
;
Seo, Ji-Heui
;
Davidsohn, Matthew P.
...
Nature Medicine. 29 (2023) 11 - p. 2737-2741 , 2023
Link:
https://doi.org/10.1038/..
?
11
Health-related quality of life with nivolumab plus relatlim..:
Schadendorf, Dirk
;
Tawbi, Hussein
;
Lipson, Evan J.
...
European Journal of Cancer. 187 (2023) - p. 164-173 , 2023
Link:
https://doi.org/10.1016/..
?
12
First-in-human phase I study of the OX40 agonist GSK3174998..:
Postel-Vinay, Sophie
;
Lam, Vincent K
;
Ros, Willeke
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 3 - p. e005301 , 2023
Link:
https://doi.org/10.1136/..
?
13
Author Correction: Liquid biopsy epigenomic profiling for c..:
Baca, Sylvan C.
;
Seo, Ji-Heui
;
Davidsohn, Matthew P.
...
Nature Medicine. 30 (2023) 3 - p. 907-907 , 2023
Link:
https://doi.org/10.1038/..
?
14
Granulocyte–Macrophage Colony-Stimulating Factor Influence ..:
Li, Xiaoyu
;
Li, Jingjing
;
Zheng, Yue
...
Cancer Immunology Research. 11 (2023) 8 - p. 1100-1113 , 2023
Link:
https://doi.org/10.1158/..
?
15
EDIL3 as an Angiogenic Target of Immune Exclusion Following..:
Tabasum, Saba
;
Thapa, Dinesh
;
Giobbie-Hurder, Anita
...
Cancer Immunology Research. 11 (2023) 11 - p. 1493-1507 , 2023
Link:
https://doi.org/10.1158/..
1-15